Volume : 12, Issue : 04, April – 2025
Title:
EXPLORING NOVEL THERAPEUTIC APPROACHES FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD): ADVANCEMENTS IN PHARMACOLOGICAL, ENDOSCOPIC, AND LIFESTYLE INTERVENTIONS
Authors :
Muhammad Fahad Khaliq, Jatindar, Haresh Kumar,Muhammad Mudassar Shoaib, Muhammad Awais Latif, Abida Wali
Abstract :
Background: Doctor treat patients with Gastroesophageal Reflux Disease (GERD) which shows itself through continuous gastrointestinal issues that force stomach contents up towards the esophagus and brings about heartburn and regurgitation. Medical treatments primarily based on acid suppression have shown limited success in treating the symptoms while also failing to treat the biological cause of GERD. Multiple therapeutic gains occurred through recent industrial improvements in endoscopic procedures along with pharmacological therapies and lifestyle interventions.
Aim: The research evaluated the success of innovative GERD treatment methods which involved contemporary pharmaceutical drugs alongside endoscopic approaches and structured life adjustments.
Methods: The research took place at Allied Hospital Faisalabad throughout February 2024 to January 2025. The study enrolled 100 patients who received GERD diagnosis through clinical evaluation and endoscopic assessment. Researchers separated their participants into groups based on their treatment strategy which included either advanced pharmacological medicine or endoscopic procedures against lifestyle adjustment plans. The research obtained data by conducting patient interviews supported with symptom score assessments and six-month follow-up evaluations.
Results: A total of 100 participants received treatment including 35 patients who received advanced pharmacological medicines and 30 patients who received endoscopic therapy while 35 patients followed structured lifestyle programs. Symptomatic improvement occurred in 85% of patients in the pharmacological group combined with 80% in the endoscopic group and 70% in the lifestyle group. Those patients who received treatment combination between pharmacological therapy and lifestyle changes achieved the maximum symptom reduction alongside the lowest recurrence rates. The various treatment methods produced few adverse side effects among patients.
Conclusion: This research demonstrated the rising effectiveness of new medical treatments used to manage GERD. Both advanced pharmacological drugs and endoscopic techniques which maintained minimally invasive characteristics together with lifestyle changes yielded enhanced symptom relief alongside better patient quality of life. The research evidence exemplifies the need for individualized treatment plans for GERD patients.
Keywords: GERD, Gastroesophageal Reflux Disease, Pharmacological Therapy, Endoscopic Intervention, Lifestyle Modification, Allied Hospital Faisalabad.
Cite This Article:
Please cite this article in press Muhammad Fahad Khaliq et al., Exploring Novel Therapeutic Approaches For Gastroesophageal Reflux Disease (Gerd): Advancements In Pharmacological, Endoscopic, And Lifestyle Interventions.,, Indo Am. J. P. Sci, 2025; 12(04).
Number of Downloads : 10
References:
1. Pradhan S, Sarkar DB. An Insight Into Gastro Esophagal Reflux Disease And It Management To Alternative Medicine And Lifestyle Changes. RPS Pharmacy and Pharmacology Reports. 2025 Jan 20:rqaf001.
2. Pandolfino J. Emerging Concepts in GERD and Esophageal Motility Disorders Symposium. 2025 消化系聯合學術演講年會.:19.
3. Komolafe K, Komolafe TR, Crown OO, Ajiboye B, Noubissi F, Ogungbe IV, Graham B. Natural Products in the Management of Gastroesophageal Reflux Disease: Mechanisms, Efficacy, and Future Directions. Nutrients. 2025 Mar 19;17(6):1069.
4. Wickramasinghe N, Devanarayana NM. Unveiling the intricacies: Insight into gastroesophageal reflux disease. World Journal of Gastroenterology. 2025 Jan 7;31(1):98479.
5. Caterbi S, Buttarini C, Garetto S, Franco Moscardini I, Ughetto S, Guerrini A, Panizzi E, Rumio C, Mattioli L, Perfumi M, Maidecchi A. A Non-Pharmacological Paradigm Captures the Complexity in the Mechanism of Action of Poliprotect Against Gastroesophageal Reflux Disease and Dyspepsia. International Journal of Molecular Sciences. 2025 Jan 29;26(3):1181.
6. Farah A, Assaf T, Hindy J, Abboud W, Mahamid M, Savarino EV, Mari A. The Dynamic Evolution of Eosinophilic Esophagitis. Diagnostics. 2025 Jan 21;15(3):240.
7. Zhang L, Chu Q, Jiang S, Shao B. Genetic evidence for amlodipine’s protective role in gastroesophageal reflux disease: A focus on CACNB2. PloS one. 2025 Feb 18;20(2):e0309805.
8. Wang XY, Chen HY, Sun Q, Li MH, Xu MN, Sun T, Huang ZH, Zhao DL, Li BR, Ning SB, Fan CX. Global trends and research hotspots in esophageal strictures: A bibliometric study. World Journal of Gastrointestinal Surgery. 2025 Mar 27;17(3):100920.
9. Ahmed K, Rauf SA, Hussain T, Siddiqui A, Ahmed R, Khan NA, Shah HH, Haque MA. Evolving therapeutic approaches in achalasia: a comprehensive review of peroral endoscopic myotomy (POEM) vs. Heller’s myotomy. Annals of Medicine and Surgery. 2025:10-97.
10. Lan CC, Lee C, Jao LY, Wu YK, Huang KL, Su WL, Huang YC, Wu CW, Yang MC. Interrelationship Between Obstructive Sleep Apnea Syndrome and Small Airway Disease: A Comprehensive Review. Biomedicines. 2025 Apr 8;13(4):905.
11. Lan CC, Lee C, Jao LY, Wu YK, Huang KL, Su WL, Huang YC, Wu CW, Yang MC. Interrelationship Between Obstructive Sleep Apnea Syndrome and Small Airway Disease: A Comprehensive Review. Biomedicines. 2025 Apr 8;13(4):905.
12. Farah A, Savarino EV, Abboud W, Tatakis A, Mari A. The Contemporary Diagnostic Approaches to Esophageal Symptomatology. Cureus. 2025 Feb 10;17(2).
13. Al Lawati A, Alhabsi A, Rahul R, Savino ML, Alwahaibi H, Das S, Al Lawati H. Current and Emerging Parenteral and Peroral Medications for Weight Loss: A Narrative Review. Diseases. 2025 Apr 22;13(5):129.
14. Che PY, Zuo CJ, Tian J. Global trends in esophageal cancer and metabolic syndrome research: bibliometric analysis and visualization from 1995 to 2024. Discover Oncology. 2025 Dec;16(1):1-24.
15. Huang Z, Zhu J, Bu X, Lu S, Luo Y, Liu T, Duan N, Wang W, Wang Y, Wang X. Probiotics and prebiotics: new treatment strategies for oral potentially malignant disorders and gastrointestinal precancerous lesions. npj Biofilms and Microbiomes. 2025 Apr 8;11(1):55.